Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +55.72%
#3 Ontology Gas Ontology Gas +36.94%
#4 DogBull DogBull +36.89%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +21.85%
#7 Collect on Fanable Collect on Fanable +21.43%
#8 Nockchain Nockchain +19.56%
#9 Pump.fun Pump.fun +19.14%
#10 Unit Pump Unit Pump +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Pozycja w akcjach #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Cena akcji
$0.12164306
Ostatnia synchronizacja: 2024-11-11
Kapitalizacja rynkowa
$38.53M
Zmiana (1 dzień)
-4.14%
Zmiana (1 rok)
0.00%
Kraj
AU
Handel PharmAust Limited (PAA)

Kategoria

Healthcare
Wskaźnik P/B dla PharmAust Limited (PAA)
Wskaźnik P/B na dzień August 2026 TTM: 8.34
Według najnowszych raportów finansowych i ceny akcji PharmAust Limited, obecny wskaźnik P/B (TTM) wynosi 8.34. Na koniec 2024 wynosił 7.07.
Historia wskaźnika P/B dla PharmAust Limited od 2001 do 2026
Wskaźnik P/B na koniec każdego roku
Rok Wskaźnik P/B Zmień
2026 (TTM) 8.34 -66.96%
2025 25.24 257.09%
2024 7.07 14.20%
2023 6.19 118.92%
2022 2.83 -12.60%
2021 3.24 -39.88%
2020 5.38 357.35%
2019 1.18 54.04%
2018 0.76 -23.38%
2017 1.00 -25.35%
2016 1.34 27.23%
2015 1.05 -36.35%
2014 1.65 -90.55%
2013 17.45 671.52%
2012 2.26 -68.36%
2011 7.15 99.09%
2010 3.59 333.85%
2009 0.83 5.81%
2008 0.78 -13.33%
2007 0.90 -33.57%
2006 1.36 -44.16%
2005 2.43 -64.38%
2004 6.83 667.26%
2003 0.89 -50.23%
2002 1.79 19.65%
2001 1.49 0.00%
Wskaźnik P/B dla podobnych firm lub konkurentów
Firma Wskaźnik P/B Różnica wskaźnika P/B Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -23.94%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -25.15%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -69.95%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -55.52%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH